To Win at All Costs (opens in new tab)

To Win at All Costs by Meryl Nass at Brownstone Institute Bayer bought Monsanto in 2018 for $63 billion —a few months before Monsanto lost its first liability case for causing non-Hodgkins lymphoma. I was not a close observer of the case, but the win seemed to hinge on documents obtained during discovery that revealed Monsanto knew a great deal about the injuries its product caused but deliberately hid those findings. Once there was a win—and the jury awarded the plaintiff with non-Hodgkin’s ...